Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progres
about
Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progeniesCirculating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.Incremental value of magnetic resonance imaging in the advanced management of prostate cancer.Comprehensive proteome analysis of an Apc mouse model uncovers proteins associated with intestinal tumorigenesis.Association of obesity and smoking with PSA and PSA velocity in men with prostate cancer.The top 13: what family physicians should know about prostate cancerProstate specific antigen for early detection of prostate cancer: longitudinal study.Risks and benefits of dietary isoflavones for cancer.Downregulation of key regulatory proteins in androgen dependent prostate tumor cells by oncolytic reovirus.Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signalingKLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone.Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer.Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men
P2860
Q31049380-14A6737F-8394-4411-AC84-8491286D6AB9Q33408667-B08A4CC2-226F-4A76-BC44-236B11C3A0DCQ33772524-7C96EB4E-CA08-4241-8CFC-68F1863F152EQ33870460-068CC894-E364-4DE1-A938-C62FB2A7B31CQ35924445-90BF8CD9-E236-4D92-BE85-79470BA52CBBQ36516395-EF1CDB26-D108-4E40-B3C8-61DEF4EDBB0BQ37362535-5C850671-8D75-4BD5-B422-2A6B03A2CC98Q37857841-42B51BB3-D0F2-4FFD-AE9D-6B743CE71923Q38844346-3585410F-3540-40D1-9381-F058060944BCQ39665818-E41F3A80-7155-4504-B3DB-64CB68ECD068Q39744334-3CF2C764-3937-4443-B650-F7A21F3F5D28Q40373750-E62F6804-DA79-40B6-B932-1561FFB7C666Q57710782-79FB7A22-EDA2-478E-8465-161B7C5462BF
P2860
Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progres
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Evidence-based medical perspec ...... for the prevention and progres
@ast
Evidence-based medical perspec ...... for the prevention and progres
@en
type
label
Evidence-based medical perspec ...... for the prevention and progres
@ast
Evidence-based medical perspec ...... for the prevention and progres
@en
prefLabel
Evidence-based medical perspec ...... for the prevention and progres
@ast
Evidence-based medical perspec ...... for the prevention and progres
@en
P1476
Evidence-based medical perspec ...... for the prevention and progres
@en
P2093
Ronald Lieberman
P304
P356
10.1097/01.MJT.0000141604.20320.0C
P577
2004-11-01T00:00:00Z